Children aged 12 to 17 years can now get the Serum Institute's coronavirus vaccine Covovax at private centres with a provision for it being made on the CoWIN portal, official sources said on Monda...

An expert panel of India's central drug authority has recommended permission for conducting a phase-3 clinical trial of Covid vaccine Covovax as a booster dose in adults, official sources said on ...

Central government is expected to arrive on a decision soon on the possibility of using the two new Covid vaccines that have been approved today as booster jabs. According to an NDTV report deliberati...

Vaccine major Serum Institute of India (SII) on Tuesday said the approval for the COVID-19 vaccine 'Covovax' would strengthen immunization initiatives across India and various lower and middle...

  Union Health Minister Mansukh Mandaviya on Tuesday said that the Central Drug Authority CDSCO has approved the Serum Institute of India's COVID-19 vaccine Covovax, Biological E's jab C...

SII already manufactures Covishield in collaboration with AstraZeneca. Earlier this week, Poonawalla had said that SII planned to launch Covovax in the next six months. He had stated that Covovax wou...

  The Indian government has permitted export of 5 crore doses of Covovax, a COVID-19 vaccine domestically produced here by the Serum Institute of India (SII), as the jab has not yet been approve...

Top heart surgeon Dr Naresh Trehan has warned of a potential medical disaster if authorities rush to open schools before children are vaccinated against Covid-19. He says India needs to look at the US...

Serum Institute of India CEO Adar Poonawalla on Friday said he is hopeful that Covovax, another COVID-19 vaccine being manufactured by his company in India, will be launched in October for adults and ...

The first batch of Covovax, a Covid-19 vaccine developed by Novavax Inc, is being manufactured at the Serum Institute of India's Pune facility, SII CEO Adar Poonawalla said on Friday. "Excit...